Genmab — Marts 2021
-
Hvis JNJ ikke udnytter optionen på hexa-cd38, så kan Genmab køre videre alene udenfor MM, f.eks. i leukemi
-
et vigtigt incitament i pharmabranchen er også at komme først til markedet...
-
Ny video.
Teknisk analyse af 4 danske life science selskaber.
Novo Nordisk
Genmab
Bavarian
Zealand Pharma -
optionen skal senest udnyttes når der er resultat fra 2 kliniske studier
-
Multiple-myeloma-fact-sheet.pdf https://gco.iarc.fr/today/data/factsheets/cancers/35-Multiple-myeloma-fact-sheet.pdf
-
WHO
https://gco.iarc.fr/tomorrow/en/dataviz/trends?types=0&sexes=1_2&mode=cancer&group_populations=0&multiple_populations=0&multiple_cancers=1&cancers=35&populations=908 https://gco.iarc.fr/tomorrow/en/dataviz/tables?types=0&sexes=0&mode=cancer&group_populations=1&multiple_populations=0&multiple_cancers=1&cancers=35&populations=900
-
Det er da billigere at sætte genmab af vog
nen....
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind